These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 20945414)
1. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells. Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414 [TBL] [Abstract][Full Text] [Related]
2. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis. Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250 [TBL] [Abstract][Full Text] [Related]
4. GSK3 is a regulator of RAR-mediated differentiation. Gupta K; Gulen F; Sun L; Aguilera R; Chakrabarti A; Kiselar J; Agarwal MK; Wald DN Leukemia; 2012 Jun; 26(6):1277-85. PubMed ID: 22222598 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells. Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008 [TBL] [Abstract][Full Text] [Related]
6. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999 [TBL] [Abstract][Full Text] [Related]
7. Expression, protein stability and transcriptional activity of retinoic acid receptors are affected by microtubules interfering agents and all-trans-retinoic acid in primary rat hepatocytes. Dvorák Z; Vrzal R; Ulrichová J; Macejová D; Ondková S; Brtko J Mol Cell Endocrinol; 2007 Mar; 267(1-2):89-96. PubMed ID: 17291686 [TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation. Fang Y; Zhou X; Lin M; Jing H; Zhong L; Ying M; Luo P; Yang B; He Q Cancer Biol Ther; 2010 Dec; 10(11):1157-67. PubMed ID: 20935519 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454 [TBL] [Abstract][Full Text] [Related]
10. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells. Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283 [TBL] [Abstract][Full Text] [Related]
11. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271 [TBL] [Abstract][Full Text] [Related]
12. Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α. Zhou Q; Zhang L; Chen Z; Zhao P; Ma Y; Yang B; He Q; Ying M FEBS J; 2014 Jul; 281(13):3032-47. PubMed ID: 24819975 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region. Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells. Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells. Wu Q; Lin XF; Ye XF; Zhang B; Xie Z; Su WJ J Mol Endocrinol; 2004 Jun; 32(3):595-613. PubMed ID: 15171703 [TBL] [Abstract][Full Text] [Related]
16. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines. Grande A; Montanari M; Manfredini R; Tagliafico E; Zanocco-Marani T; Trevisan F; Ligabue G; Siena M; Ferrari S; Ferrari S Cell Death Differ; 2001 Jan; 8(1):70-82. PubMed ID: 11313705 [TBL] [Abstract][Full Text] [Related]
17. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation. Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565 [TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation. Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251 [TBL] [Abstract][Full Text] [Related]
19. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]